This Lululemon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have downgraded their ratings for several notable companies, including Lululemon Athletica Inc., Zions Bancorporation, Edwards Lifesciences Corporation, Lamb Weston Holdings, Inc., and MaxLinear, Inc. These downgrades reflect a more cautious outlook on these stocks.
July 25, 2024 | 2:48 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
B of A Securities analyst Travis Steed downgraded Edwards Lifesciences Corporation from Buy to Neutral and lowered the price target from $105 to $75. Edwards Lifesciences shares closed at $86.95 on Wednesday.
The downgrade and significant reduction in price target suggest a less favorable outlook for Edwards Lifesciences, likely leading to a short-term decline in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Citigroup analyst Paul Lejuez downgraded Lululemon Athletica Inc. from Buy to Neutral and cut the price target from $415 to $300. Lululemon shares settled at $272.06 on Wednesday.
The downgrade from Buy to Neutral and significant reduction in price target suggests a less optimistic outlook for Lululemon, likely leading to a short-term decline in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Stifel analyst Matthew Smith downgraded Lamb Weston Holdings, Inc. from Buy to Hold and slashed the price target from $115 to $60. Lamb Weston shares closed at $56.42 on Wednesday.
The downgrade and drastic reduction in price target indicate a more cautious outlook for Lamb Weston, likely leading to a short-term decline in stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 85
NEGATIVE IMPACT
Needham analyst Quinn Bolton downgraded MaxLinear, Inc. from Buy to Hold. MaxLinear shares closed at $22.29 on Wednesday.
The downgrade from Buy to Hold suggests a more cautious stance on MaxLinear, which may result in a short-term negative impact on the stock price.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 75
NEGATIVE IMPACT
Argus Research analyst Kevin Heal downgraded Zions Bancorporation from Buy to Hold. Zions Bancorp shares closed at $50.98 on Wednesday.
The downgrade from Buy to Hold indicates a more cautious stance on Zions Bancorp, which may result in a short-term negative impact on the stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80